Showing 381-390 of 2253 results for "".
Case Conference: When ‘3-for-5’ Is Not Enough
https://practicalneurology.com/diseases-diagnoses/imaging-testing/case-conference-when-3-for-5-is-not-enough/31893/Beware of diagnostic ‘bycatch’ when using screening testsCase Report: New-Onset Headache With Tinnitus and Orthostatic Dizziness
https://practicalneurology.com/diseases-diagnoses/headache-pain/case-report-new-onset-headache-with-tinnitus-andorthostatic-dizziness/31546/All headaches require a full workup for secondary causes.Headache Horizons: Headaches That Roam the Night
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-headaches-that-roam-the-night/31636/Many headache types can occur in the night, including some that may be exclusive to dream periods.Is There a Place for Spirituality in Neurology?
https://practicalneurology.com/columns/practice-management/is-there-a-place-for-spirituality-in-neurology/31937/Being comfortable with spirituality may improve care in multiple ways.Migraine in Children and Adolescents
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-in-children-and-adolescents/31999/Pediatric migraines differ from adult migraines and warrant a distinct approach to treatment.Behavioral Approaches in Dementia Care
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/behavioral-approaches-in-dementia-care/31800/The many behavioral and psychologic symptoms of dementia have a large effect on patient and caregiver outcomes.Headache in Dysautonomia & “Long COVID”/PASC
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-in-dysautonomia-long-covidpasc/31899/Frequent and long-lasting headaches are a common symptom of autonomic disorders and long COVID / postacute sequelae of SARS-CoV-2 infection (PASC).Intranasal Acute Migraine Treatments
https://practicalneurology.com/diseases-diagnoses/headache-pain/intranasal-acute-migraine-treatments/32128/Intranasal options for acute migraine treatment provide rapid-onset relief, especially for people with nausea, vomiting, or gastroparesis; needle phobia; or intolerance to injectable formulations.Late-Onset Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/late-onset-epilepsy/31945/As the population ages, late-onset epilepsy is becoming a major public health issue with effective treatments and modifiable risk factors.Multiple Sclerosis Minute: Natalizumab Extended-Interval Dosing
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-natalizumab-extended-interval-dosing/31647/The extended interval dosing approach for natalizumab treatment reduces the risk of progressive multifocal leukoencephalopathy.